解码 BIO 协议和 DeSci 的远大梦想

随着BIO协议推出的临近，DeSci（去中心化科学）生态系统中的代币价格飙升。

As the launch of the BIO Protocol nears, tokens in the Decentralized Science (DeSci) ecosystem have seen a surge in value.

随着 BIO 协议发布的临近​​，去中心化科学（DeSci）生态系统中的代币价值飙升。

This excitement has continued from the launch of tokens associated with cutting-edge technologies like DeSci and AI, with the boundary remaining blurred as tokens associated with these technologies have seen a surge in value leading up to the launch of BIO. Being a key hub for DeSci financing, the introduction of BIO has brought hope to DeSci, with the highly experimental field garnering attention from the outside world and attracting more attention and capital to DeSci over time.

自 DeSci 和 AI 等尖端技术相关代币的推出以来，这种兴奋一直持续不断，但由于与这些技术相关的代币在 BIO 推出之前价值飙升，因此边界仍然模糊。作为DeSci融资的重要枢纽，BIO的引入给DeSci带来了希望，这个高度实验性的领域受到了外界的关注，也随着时间的推移为DeSci吸引了更多的关注和资本。

This article will explore how the BIO Protocol functions, the challenges it aims to address, and the DAOs operating under its protection. It will then explore how other projects fill the DeSci narrative and provide additional tools or use cases to transform scientific collaboration and funding.

本文将探讨 BIO 协议的运作方式、其旨在解决的挑战以及在其保护下运行的 DAO。然后，它将探索其他项目如何填补 DeSci 的叙述，并提供额外的工具或用例来改变科学合作和资助。

The BIO Protocol is essentially a decentralized, token-governed platform that supports and incubates specialized BioDAOs. By incorporating funding decisions, intellectual property ownership, and governance on-chain, several long-standing barriers in the biotechnology field are directly addressed by the protocol:

BIO 协议本质上是一个去中心化、代币管理的平台，支持和孵化专门的 BioDAO。通过将资金决策、知识产权所有权和链上治理结合起来，该协议直接解决了生物技术领域的几个长期存在的障碍：

To achieve these goals, several core mechanisms are implemented by BIO.

为了实现这些目标，BIO 实现了几个核心机制。

BIO holders can lock their tokens (vBIO) to help decide which new BioDAOs are admitted into the network.

BIO 持有者可以锁定他们的代币 (vBIO)，以帮助决定哪些新的 BioDAO 被允许进入网络。

This process ensures that only the most promising or community-supported ventures are admitted, as those committing to support must stake BIO for a certain period. If approved, stakers can exclusively participate in the funding rounds of the BioDAOs.

这个过程确保只有最有前途或最受社区支持的企业才能被接纳，因为那些承诺支持的企业必须在一段时间内持有 BIO。如果获得批准，利益相关者可以独家参与 BioDAO 的融资轮次。

After the curation phase is completed, private seed pre-auctions are opened by BioDAOs for those who have locked vBIO.

管理阶段完成后，BioDAO 将为锁定 vBIO 的人开放私人种子预拍卖。

This allows early supporters of the DAO and the BIO community to participate in the funding of early-stage scientific research on terms traditionally reserved for VCs. Meanwhile, the liquidity is handled by the BIO Protocol on behalf of these BioDAOs, eliminating the need for them to oversee secondary markets. The BIO treasury pairs tokens (e.g., VITA/BIO or HAIR/BIO) with ETH or other assets to generate fees for the protocol while ensuring stable trading pairs. This arrangement allows BioDAOs to focus on advancing research rather than being preoccupied with market operations.

这使得 DAO 和 BIO 社区的早期支持者能够以传统上为 VC 保留的条款参与早期科学研究的资助。与此同时，流动性由 BIO 协议代表这些 BioDAO 处理，从而消除了它们监督二级市场的需要。 BIO 金库将代币（例如 VITA/BIO 或 HAIR/BIO）与 ETH 或其他资产配对，以产生协议费用，同时确保稳定的交易对。这种安排使 BioDAO 能够专注于推进研究，而不是专注于市场运营。

Since a portion of each BioDAO token is held by the BIO treasury, BIO holders collectively gain influence within the broader DeSci ecosystem.

由于每个 BioDAO 代币的一部分由 BIO 金库持有，因此 BIO 持有者共同在更广泛的 DeSci 生态系统中获得影响力。

This meta-governance structure enables them to guide decisions across multiple BioDAOs, whether determining research priorities or emphasizing synergies between projects. Additionally, by diversifying the assets held by the treasury, the protocol enhances its ability to invest in new projects and reinvest in existing ones, thereby achieving seamless coordination in the ever-expanding field of scientific research.

这种元治理结构使他们能够指导多个 BioDAO 的决策，无论是确定研究重点还是强调项目之间的协同作用。此外，通过使财政部持有的资产多样化，该协议增强了其投资新项目和再投资现有项目的能力，从而在不断扩大的科学研究领域实现无缝协调。

To incentivize clear and measurable contributions to its network, BIO issues "bio/acc rewards" in the form of additional BIO tokens to BioDAOs that achieve key milestones. In addition to these incentives, BioDAOs can also tokenize their IP (from research data to patents). By issuing IP tokens, BioDAOs can grant partial ownership of their research outcomes, allowing more stakeholders to benefit from future scientific breakthroughs while retaining control over key decisions and potentially earning from the use of their data.

为了激励对其网络做出明确且可衡量的贡献，BIO 以额外 BIO 代币的形式向实现关键里程碑的 BioDAO 发放“bio/acc 奖励”。除了这些激励措施之外，BioDAO 还可以将其知识产权（从研究数据到专利）代币化。通过发行 IP 代币，BioDAO 可以授予其研究成果的部分所有权，使更多利益相关者能够从未来的科学突破中受益，同时保留对关键决策的控制权并从使用其数据中获得潜在收益。

Beyond direct incentives, the overall value of the network also grows through token distribution and liquidity owned by the protocol. Grants to new BioDAOs can be exchanged for a small equity stake in their tokens, while liquidity pool fees flow back to the treasury. As BioDAOs mature and generate tangible results, the total value of these assets will increase, reinforcing a virtuous cycle of funding, growth, and innovation.

除了直接激励之外，网络的整体价值还通过代币分配和协议拥有的流动性来增长。对新 BioDAO 的资助可以换取其代币的少量股权，而流动性池费用则回流至财政部。随着 BioDAO 的成熟并产生切实的成果，这些资产的总价值将会增加，从而加强融资、增长和创新的良性循环。

Currently, there are eight active BioDAOs in the BIO network, each focusing on specific research areas.

目前，BIO 网络中有八个活跃的 BioDAO，每个都专注于特定的研究领域。

VitaDAO was launched in 2021 to support research aimed at extending the human lifespan. Funded by Pfizer Ventures and Balaji Srinivasan, it explores the biological mechanisms of aging, including neurodegenerative diseases.

VitaDAO 于 2021 年推出，旨在支持旨在延长人类寿命的研究。该项目由辉瑞风险投资公司和 Balaji Srinivasan 资助，探索衰老的生物学机制，包括神经退行性疾病。

Quantum Biology DAO studies how weak magnetic fields affect cells at the quantum level. It collaborates with the Quantum Biology Institute to develop quantum microscopes, opening new avenues for longevity research, drug discovery, and more.

量子生物学 DAO 研究弱磁场如何在量子水平上影响细胞。它与量子生物学研究所合作开发量子显微镜，为长寿研究、药物发现等开辟新途径。

HairDAO unites patients, researchers, and funders to collaboratively address the resource scarcity issue of hair loss.

HairDAO 将患者、研究人员和资助者联合起来，共同解决脱发的资源稀缺问题。

ValleyDAO is dedicated to seeking synthetic biology solutions to combat climate change, such as engineering microbes to capture carbon dioxide or produce biodegradable materials.

ValleyDAO 致力于寻求合成生物学解决方案来应对气候变化，例如改造微生物来捕获二氧化碳或生产可生物降解材料。

AthenaDAO focuses on women's health, filling gaps neglected by traditional funding. Through a decentralized community of patients, scientists, and advocates, it supports projects on reproductive health, hormonal disorders, and other under-researched topics in female biology.

AthenaDAO 专注于女性健康，填补传统资金忽视的空白。通过由患者、科学家和倡导者组成的分散社区，它支持生殖健康、荷尔蒙失调和女性生物学中其他研究不足的主题的项目。

CryoDAO allocates funding for cryopreservation research to improve the storage of organs and tissues, a solution with life-saving potential.

CryoDAO 为冷冻保存研究分配资金，以改善器官和组织的储存，这是一种具有挽救生命潜力的解决方案。

PsyDAO focuses on psychedelic research for mental health issues such as depression, addiction, and PTSD. It employs a decentralized funding model and AI-based auditing to accelerate the exploration of new compounds, while on-chain governance ensures transparency in resource allocation.

PsyDAO 专注于抑郁症、成瘾和创伤后应激障碍等心理健康问题的迷幻研究。它采用去中心化的融资模式和基于人工智能的审计来加速新化合物的探索，而链上治理则确保资源分配的透明度。